TGTX

NASDAQ · Biotechnology

Tg Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$59.83

+1.85 (+3.18%)

As of Nov 7, 1:30 AM ET ·

TGTX News1 articles

TG Therapeutics Stock Drops 9.8% Despite Strong BRIUMVI Sales as Costs Surge

TG Therapeutics shares fell 9.8% as Q2 revenue rose 70% but operating income declined 38% on surging costs. Guidance raised modestly.